Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Jun 24, 2021 6:58am
169 Views
Post# 33440117

Rapid Antigen Tests

Rapid Antigen Tests

This was from a Canadian article this morning:

"Rapid antigen tests are effective in determining when transmission of COVID-19 is most likely to occur,” said Dr. Adam Faller, post doctorate fellow in genomics at the University of Guelph. “The vaccines in place today were developed for the original strain of the virus. As the virus evolves and more transmissible variants emerge, rapid antigen tests, along with laboratory-based PCR tests, remain important tools in helping people determine how to best manage COVID-19.”
 

https://www.businesswire.com/news/home/20210624005035/en/Haven-Testing-to-Make-Rapid-COVID-19-Antigen-Tests-Available-for-Home-Use-in-Ontario

The company in question had their test approved by HC in February. Not sure why it's taken this long to suddenly start marketing it. From the same article :

“While it’s great that businesses have the opportunity to obtain rapid antigen tests, we believe the demand spans well beyond business,” said JP Bhavnani, managing partner of Haven Testing.

With cases climbing in several countries in South America including Brazil, Columbia (mentioned in a recent NR by THRM) and Peru and many countries in Africa AcuVid has significant potential to change the trajectory.

As an aside the Haven Test has a Sensitivity of 92% and costs $20 per test.

GLTE ...holding patiently!!!

 

 

 

<< Previous
Bullboard Posts
Next >>